WWW.PERFECTDISPLAY.COM - Where Technology Converges

BioForce's BioMolecular Nanoplacement System Selected for Nanomaterial Development

Home
Beauty and Health
EDA News
Medical Technology Journal
Micromachnes and Nanomachines Database
Semiconductor Evening News
World Energy Technololgy
NAVIGATION
E-MAGAZINES
E-DIRECTORIES
NEWSWIRES
PRESENTATIONS
BUSINESS INTELLIGENCE
Rebuilding New Orleans
Story Book Corner - Coloring Books and More
SEARCH THE SITE
IC Companies By Alphabet - S
NFL Football
List Your Company Profile
Halloween Fun
Greeting Cards

To list your company's press release on our NewsWire, send your press release to marketing@perfectdisplay.com.

September 1st, 2005
 
 
North Carolina State University (NCSU) has selected the NanoArrayer System from  BioForce Nanosciences for use in the laboratory of Dr. Dan Feldheim, Professor of Chemistry. The system is expected to be used at the facility for research into RNA sequences that can act as catalysts for the formation of nanomaterials. Noting that BioForce will be part of the research effort at NCSU was Dr. Eric Henderson, CEO at BioForce Nanosciences, "The NanoArrayer System provides a unique solution to the problem Dr. Feldheim faces of ultramicro-scale deposition of femtoliter volumes on specialized surfaces developed in his laboratory. In addition to providing this technology, we will also be working with this research group at a collaborative level as they further develop their powerful and novel molecular screening process."
 
Dr. Feldheim and a team of researchers, which included Professor Bruce Eaton at The University of Colorado, recently discovered that RNA sequences can act as central catalytic forces used in the formation of metallic nanomaterials. It was also indicated that these new nanomaterials could be useful in the fields of alternative energy and medical imaging. As well, according to Dr. Curtis Mosher, Vice President of Research and Development at BioForce, "This technology has significant market potential in several areas including Molecular Diagnostics, Molecular Detection and Pharma Discovery."

 
Copyright 2004, 2005, Mark C. Stansberry, All Rights Reserved
 
TERMS OF USE
 
The publisher of this web site does not certify that the information contained on this web site is 100 percent accurate. Use of this web site requires that the reader release the publisher from all liability that may result from the reliance of information on this web site. The publisher suggests that readers verify any information contained on this web site with three or more other reference sources, as well as directly with any company(s) mentioned. Please report any errors or omissions to marketing@perfectdisplay.com.
 
The site may include words, or phrases that are specific trademarks of companies mentioned.